Novel insights into the cardio-protective effects of FGF21 in lean and obese rat hearts.
<h4>Aims</h4>Fibroblast growth factor 21 (FGF21) is a hepatic metabolic regulator with pleotropic actions. Its plasma concentrations are increased in obesity and diabetes; states associated with an increased incidence of cardiovascular disease. We therefore investigated the direct effect...
Enregistré dans:
Auteurs principaux: | , , , , , , , , |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2014
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/1e31b47f830c4c7d9cea277508f5121a |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|